Systems biology analysis reveals NFAT5 as a novel biomarker and master regulator of inflammatory breast cancer

[1]  Daniel Birnbaum,et al.  Genomic profiling of inflammatory breast cancer: a review. , 2014, Breast.

[2]  Antonella Santone,et al.  De novo reconstruction of gene regulatory networks from time series data, an approach based on formal methods. , 2014, Methods.

[3]  M. Ceccarelli,et al.  Comparison between invasive breast cancer with extensive peritumoral vascular invasion and inflammatory breast carcinoma: a clinicopathologic study of 161 cases. , 2014, American journal of clinical pathology.

[4]  J. Yokota,et al.  MAX inactivation in small cell lung cancer disrupts MYC-SWI/SNF programs and is synthetic lethal with BRG1. , 2014, Cancer discovery.

[5]  G. Falco,et al.  Identification of a Novel Gene Signature of ES Cells Self-Renewal Fluctuation through System-Wide Analysis , 2014, PloS one.

[6]  J. Li,et al.  Wnt modulates MCL1 to control cell survival in triple negative breast cancer , 2014, BMC Cancer.

[7]  C. Moreno,et al.  Wnt signaling blockage inhibits cell proliferation and migration, and induces apoptosis in triple-negative breast cancer cells , 2013, Journal of Translational Medicine.

[8]  Kerstin B. Meyer,et al.  Master regulators of FGFR2 signalling and breast cancer risk , 2013, Nature Communications.

[9]  G. Landberg,et al.  Wnt Pathway Activity in Breast Cancer Sub-Types and Stem-Like Cells , 2013, PloS one.

[10]  H. Weiss,et al.  NFAT5 represses canonical Wnt signaling via inhibition of β-catenin acetylation and participates in regulating intestinal cell differentiation , 2013, Cell Death and Disease.

[11]  F. Bertucci,et al.  Uncovering the Molecular Secrets of Inflammatory Breast Cancer Biology: An Integrated Analysis of Three Distinct Affymetrix Gene Expression Datasets , 2013, Clinical Cancer Research.

[12]  J. Downing,et al.  High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterations. , 2012, Blood.

[13]  C. Niehrs.  The complex world of WNT receptor signalling , 2012, Nature Reviews Molecular Cell Biology.

[14]  M. Boisserie-Lacroix.  The inflammatory breast. , 2012, Diagnostic and interventional imaging.

[15]  Gabriele Sales,et al.  parmigene - a parallel R package for mutual information estimation and gene network reconstruction , 2011, Bioinform..

[16]  Daniel Birnbaum,et al.  High-Resolution Comparative Genomic Hybridization of Inflammatory Breast Cancer and Identification of Candidate Genes , 2011, PloS one.

[17]  W. Neuhofer.  Role of NFAT5 in Inflammatory Disorders Associated with Osmotic Stress , 2010, Current genomics.

[18]  Melissa Bondy,et al.  Inflammatory Breast Cancer: The Disease, the Biology, the Treatment , 2010, CA: a cancer journal for clinicians.

[19]  T. Evans,et al.  The tbx/bHLH transcription factor mga regulates gata4 and organogenesis , 2010, Developmental dynamics : an official publication of the American Association of Anatomists.

[20]  J. Uhm,et al.  The transcriptional network for mesenchymal transformation of brain tumours , 2010 .

[21]  Charles Elkan,et al.  Learning gene regulatory networks from only positive and unlabeled data , 2010, BMC Bioinformatics.

[22]  Michele Ceccarelli,et al.  articleTimeDelay-ARACNE : Reverse engineering of gene networks from time-course data by an information theoretic approach , 2010 .

[23]  N. Favale,et al.  Hypertonic induction of COX2 expression requires TonEBP/NFAT5 in renal epithelial cells. , 2009, Biochemical and biophysical research communications.

[24]  A. Bresnick,et al.  Integrin α6β4 Controls the Expression of Genes Associated with Cell Motility, Invasion, and Metastasis, Including S100A4/Metastasin* , 2009, Journal of Biological Chemistry.

[25]  R. Shamir,et al.  Regulatory networks define phenotypic classes of human stem cell lines , 2008, Nature.

[26]  F. Bertucci,et al.  Defining the molecular biology of inflammatory breast cancer. , 2008, Seminars in oncology.

[27]  G. Hortobagyi,et al.  Inflammatory breast cancer (IBC) and patterns of recurrence , 2007, Cancer.

[28]  D. di Bernardo,et al.  How to infer gene networks from expression profiles , 2007, Molecular systems biology.

[29]  S. Hilsenbeck,et al.  Molecular Heterogeneity of Inflammatory Breast Cancer: A Hyperproliferative Phenotype , 2006, Clinical Cancer Research.

[30]  Adam A. Margolin,et al.  Reverse engineering cellular networks , 2006, Nature Protocols.

[31]  Chris Wiggins,et al.  ARACNE: An Algorithm for the Reconstruction of Gene Regulatory Networks in a Mammalian Cellular Context , 2004, BMC Bioinformatics.

[32]  Leslie M. Shaw,et al.  The role of NFAT transcription factors in integrin-mediated carcinoma invasion , 2002, Nature Cell Biology.

[33]  S. Merajver,et al.  A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[34]  P. Levine,et al.  Inflammatory breast cancer: the experience of the surveillance, epidemiology, and end results (SEER) program. , 1985, Journal of the National Cancer Institute.

[35]  Carcinoma of the breast. , 1942, Journal of the American Medical Association.

[36]  A. Stout,et al.  Carcinoma of the Breast. II-Criteria of Operability. , 1943, Annals of surgery.